Abstract Local anesthetics are used broadly to prevent or reverse acute pain and treat symptoms of chronic pain. This chapter, on the analgesic aspects of local anesthetics, reviews their broad actions that affect many different molecular targets and disrupt their functions in pain processing. Application of local anesthetics to peripheral nerve primarily results in the blockade of propagating action potentials, through their inhibition of voltagegated sodium channels. Such inhibition results from drug binding at a site in the channel's inner pore, accessible from the cytoplasmic opening. Binding of drug molecules to these channels depends on their conformation, with the drugs generally having a higher affinity for the open and inactivated channel states that are induced by membrane depolarization. As a result, the effective potency of these drugs for blocking impulses increases during high-frequency repetitive firing and also under slow depolarization, such as occurs at a region of nerve injury, which is often the locus for generation of abnormal, pain-related ectopic impulses. At distal and central terminals the inhibition of voltage-gated calcium channels by local anesthetics will suppress neurogenic inflammation and the release of neurotransmitters. Actions on receptors that contribute to nociceptive transduction, such as TRPV1 and the bradykinin B2 receptor, provide an independent mode of analgesia. In the spinal cord, where local anesthetics are present during epidural or intrathecal anesthesia, inhibition of inotropic receptors, such as those for glutamate, by local anesthetics further
Introduction
Local anesthetics are widely used for the prevention and relief of both acute and chronic pain (Strichartz and Berde 2005) . The reduction or abolition of acute pain from accidental or intentional trauma (surgery) is accomplished by delivery of local anesthetics to the skin by topical application or subcutaneous infiltration, to peripheral nerve by percutaneous injection, or to the neuraxis by administration into the epidural or intrathecal spaces (Gokin and Strichartz 1999). Chronic pain symptoms are also relieved, albeit mostly temporarily, by the "nerve blocking" procedures just described. In contrast, systemic local anesthetics, administered intravenously and to much lower plasma concentrations than those used for direct nerve block, also relieve many forms of neuropathic pain in humans and in animal models, and with a therapeutic benefit that often endures for weeks, months, or longer, far outlasting the presence of the drug in vivo (Boas et al. 1982; Mao and Chen 2000) .
Mechanistic Overview
Whereas mechanisms for the nerve blocking actions of local anesthetics are relatively well understood, those that underlie the neuraxial block are probably more complex. The inhibition of neuronal voltage-gated sodium channels (VGSC) by direct binding of local anesthetics (Nau and Wang 2004) leads to failure in the generation or propagation of action potentials, the primary mechanisms for functional deficits during peripheral nerve blockade. After the delivery of local anesthetics to the epidural or intrathecal compartments, these drugs diffuse into the spinal cord where they can interact with a variety of other ion channels involved (1) in excitation/depolarization of presynaptic terminals, (2) in regulating release of neurotransmitters, and (3) with both pre-and postsynaptic receptor proteins for small neurotransmitters and neuropeptides (Gokin and Strichartz 1999). These receptors include both inotropic
